PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Checkpoint Inhibitors for Advanced or Recurrent Endometrial Cancer: A New Standard of Care?
Visit https://www.peervoice.com/QZT860 to view the entire programme with slides. After completing “Checkpoint Inhibitors for Advanced or Recurrent Endometrial Cancer: A New Standard of Care?”, participants will be able to: Discuss the rationale for checkpoint inhibitors in the management of advanced or recurrent endometrial cancer; Evaluate recent data for current and emerging checkpoint inhibitors for the management of advanced or recurrent endometrial cancer; Identify common and serious adverse events associated with checkpoint inhibitors and their management in advanced or recurrent endometrial cancer.